跳至主要内容
临床试验/NCT02063867
NCT02063867已完成不适用

Cluster-Randomized Controlled Trial of Hospitals to Reduce Healthcare-Associated Infections and Readmissions Through Routine Bathing With Antiseptic Soap and Targeted Use of Nasal Antibiotic Ointment (ABATE Infection Trial)

University of California, Irvine104 个研究点 分布在 1 个国家目标入组 53 人开始时间: 2014年4月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
53
试验地点
104
主要终点
MRSA and VRE Clinical Cultures

研究概览

简要总结

The ABATE Infection Project is a cluster randomized trial of hospitals to compare two quality improvement strategies to reduce multi-drug resistant organisms and healthcare-associated infections in non-critical care units. The two strategies to be evaluated are:

  • Arm 1: Routine Care Routine policy for showering/bathing
  • Arm 2: Decolonization Use of chlorhexidine as routine soap for showering or bed bathing for all patients Mupirocin x 5 days if MRSA+ by history, culture, or screen

Note that enrolled "subjects" represents 53 individual HCA Hospitals (representing ~190 non-critical care units) that have been randomized.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All HCA hospitals that reside in the United States
  • Note: Unit of randomization is the hospital, but the participants are hospital units

排除标准

  • Non-critical care units where chlorhexidine bathing or decolonization for MRSA+ non-critical care patients is routine
  • Pediatric, peri-partum, rehabilitation, psychiatry, and BMT units
  • Units with >30% cardiac or hip/knee orthopedic surgeries
  • Unit average length of stay <2 days
  • Patients <12 years-old
  • Patients with known allergy to mupirocin or chlorhexidine

结局指标

主要结局

MRSA and VRE Clinical Cultures

时间窗: 21 months

Methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) clinical cultures attributable to participating units. Defined as occurring \>2 days into a participating unit stay through 2 days following unit discharge

次要结局

  • Gram-negative Multi-drug Resistant Organism Clinical Cultures(21 months)
  • All-cause Bloodstream Infections(21 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Susan Huang

Associate Professor and Medical Director of Epidemiology and Infection Prevention

University of California, Irvine

研究点 (104)

Loading locations...

相似试验